Is a tricyclic antidepressant the best first-line agent in treating neuropathic pain?

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Neuropathic pain can burden patients in multiple domains and remains a challenge to treat. The success in the treatment of neuropathic pain depends on evidence-based medicine and individualized patient care.

Cite

CITATION STYLE

APA

Elmofty, D. H. (2016). Is a tricyclic antidepressant the best first-line agent in treating neuropathic pain? In You’re Wrong, I’m Right: Dueling Authors Reexamine Classic Teachings in Anesthesia (pp. 361–362). Springer International Publishing. https://doi.org/10.1007/978-3-319-43169-7_103

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free